Effects of CoEnzyme Q 10 Supplementation on Women Suffering from Episodic Migraines
Document Type
Poster
Campus where you would like to present
Ellensburg
Event Website
https://digitalcommons.cwu.edu/source
Start Date
16-5-2021
End Date
22-5-2021
Keywords
supplements, migraine, Coenzyme Q 10
Abstract
Migraine headaches effect a large portion of the human population, disrupting productivity and quality of life. Limited research suggests potential preventative properties of consuming the antioxidant, Coenzyme Q 10 (CoQ10); which could lower various migraine characteristics such as frequency, severity, and duration. For this randomized controlled trial (RCT), 70 cis-female subjects (ages 18 – 50 years) will be recruited and randomized to either a CoQ10 or a placebo supplement for three months. This trial will collect baseline and post data to see the effects of CoQ10 consumption along with regular prescribed medications on duration, frequency, and severity of migraine headaches. All data will be collected through a virtual daily journal log. Daily journal logs include a numeric rating scale (NRS) to assess pain severity, hours and minutes to record durations, and frequency is based on number of migraines recorded. We hypothesize that young to middle aged women who suffer with episodic migraines will decrease in the severity, duration, and frequency when consuming the antioxidant, CoQ10.
Recommended Citation
Coffin, Avery, "Effects of CoEnzyme Q 10 Supplementation on Women Suffering from Episodic Migraines" (2021). Symposium Of University Research and Creative Expression (SOURCE). 48.
https://digitalcommons.cwu.edu/source/2021/COTS/48
Department/Program
Health Sciences
Additional Mentoring Department
https://cwu.studentopportunitycenter.com/effects-of-coenzyme-q-10-supplementation-on-women-suffering-from-episodic-migraines/
Effects of CoEnzyme Q 10 Supplementation on Women Suffering from Episodic Migraines
Ellensburg
Migraine headaches effect a large portion of the human population, disrupting productivity and quality of life. Limited research suggests potential preventative properties of consuming the antioxidant, Coenzyme Q 10 (CoQ10); which could lower various migraine characteristics such as frequency, severity, and duration. For this randomized controlled trial (RCT), 70 cis-female subjects (ages 18 – 50 years) will be recruited and randomized to either a CoQ10 or a placebo supplement for three months. This trial will collect baseline and post data to see the effects of CoQ10 consumption along with regular prescribed medications on duration, frequency, and severity of migraine headaches. All data will be collected through a virtual daily journal log. Daily journal logs include a numeric rating scale (NRS) to assess pain severity, hours and minutes to record durations, and frequency is based on number of migraines recorded. We hypothesize that young to middle aged women who suffer with episodic migraines will decrease in the severity, duration, and frequency when consuming the antioxidant, CoQ10.
https://digitalcommons.cwu.edu/source/2021/COTS/48
Faculty Mentor(s)
Nicole Stendell-Hollis